Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Galera Therapeutics Inc.
Headquarters: Malvern, PA, United States of America
Website: http://www.galeratx.com
Year Founded: 2009
Status: Public
Industry Sector: HealthTechnology
CEO: J. Mel Sorensen, MD
Number Of Employees: 7
Enterprise Value: $140,519,466
PE Ratio: -0.1
Exchange/Ticker 1: NASDAQ:GRTX
Exchange/Ticker 2: N/A
Latest Market Cap: $2,731,700
BioCentury | Sep 20, 2024
Management Tracks
Mark Bachleda takes the helm at Eyconis
Plus: Steve Caffé to lead regulatory affairs at Disc, and updates from Stalicla and AN Venture
BioCentury | Aug 15, 2024
Finance
No sleep for the biotech bear: Restructurings abound in August
At least 20 companies have trimmed pipelines, cut staff or otherwise re-jiggered strategies in past two weeks to extend runway
BioCentury | Aug 12, 2023
Regulation
Aug. 11 Quick Takes: Janssen gains prostate cancer approval
Plus: Atreca scraps lead program, turns to ADCs and updates from ALX Oncology, Hansoh-Antengene, Foghorn, Galera, Cascade
BioCentury | Jul 31, 2023
Data Byte
Over a dozen PDUFA dates on FDA’s August calendar
Decisions due next month include Sage’s depression therapy zuranolone and candidates for two ultra-rare diseases
BioCentury | Feb 15, 2023
Deals
Feb. 15 Quick Takes: Emergent deal to grow Bavarian Nordic footprint in U.S., Europe
Plus: Maxion raises series A to develop mAbs against ion channels, GPCRs and updates from Arrowhead, Moderna, Galera, Codagenix, Nanite
BioCentury | Oct 13, 2021
Management Tracks
Harler joins IGM as president of autoimmunity and inflammation business
Plus: Precigen, Transition Bio, Shoreline, Syros, Twist, Vor and more
BioCentury | Sep 29, 2021
Management Tracks
Rawat becomes president, CBO at Fusion
Plus: Sporos, Ajax, Nanocan and NeuroSense
BioCentury | Nov 7, 2019
Financial News
More weakness among IPOs as Galera, Centogene limp into marketplace
BioCentury | Oct 16, 2019
Financial News
Oct. 15 Financial Quick Takes: Phathom, Galera, J&J earnings, RTW Investments, Azitra, MaveriX
BioCentury | Oct 11, 2019
Company News
Management tracks: Chan leaving FDA’s China office; plus Galera, Aridis and Palladio
Items per page:
1 - 10 of 29